Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01655, USA.
Clinical and Population Health Research Program, Graduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
BMC Fam Pract. 2021 Dec 20;22(1):251. doi: 10.1186/s12875-021-01599-2.
The average time to a diagnosis for people with axial spondyloarthritis (axSpA) is 7-10 years. Delayed diagnosis may result in increased structural damage, worse physical function, and worse quality of life relative to patients with a timely axSpA diagnosis. Understanding patient experiences may provide insights for how to reduce diagnostic delays.
To provide foundational knowledge about patient experiences with healthcare providers leading to an axSpA diagnosis.
We conducted an exploratory qualitative research study with six focus groups interviews with participants recruited from three rheumatology clinics within the United States (MA (n = 3); CO (n = 2); PA (n = 1)) that included a total of 26 adults (10 females, 16 males) with rheumatologist confirmed diagnosis of axSpA in 2019. Focus groups were ~ 2 h, audio recorded, transcribed, and subject to dual coding. The codes reviewed were in relation to the patients' diagnostic experiences.
Patients described frustrating and lengthy diagnostic journeys. They recognized that the causes of diagnostic delays in axSpA are multifactorial (e.g., no definitive diagnostic test, disease characteristics, lack of primary care provider's awareness about axSpA, trust). Patients described how doctors minimized or dismissed complaints about symptoms or told them that their issues were psychosomatic. Patients believed the healthcare system contributed to diagnostic delays (e.g., lack of time in clinical visits, difficulty accessing rheumatologists, health insurance challenges). Advice to physicians to reduce the diagnostic delay included allowing time for patients to give a complete picture of their illness experience, listening to, and believing patients, earlier referral to rheumatology, provision of HLA-B27 gene testing, and that physicians need to partner with their patients.
Patients desire a definitive test that could be administered earlier in the course of axSpA. Until such a test is available, patients want clinicians who listen to, believe, and partner with them, and who will follow them until a diagnosis is reached. Educating primary care clinicians about guidelines and referral for diagnosis of axSpA could reduce diagnostic delay.
对于患有中轴型脊柱关节炎(axSpA)的患者,平均确诊时间为 7-10 年。延迟诊断可能导致结构性损伤增加、身体功能更差和生活质量更差,与及时诊断 axSpA 的患者相比。了解患者的经历可能有助于了解如何减少诊断延迟。
提供有关患者与医疗保健提供者在 axSpA 诊断方面的经验的基础知识。
我们在美国的三家风湿病诊所(马萨诸塞州(n=3);科罗拉多州(n=2);宾夕法尼亚州(n=1))进行了一项探索性定性研究,共进行了六次焦点小组访谈,参与者共 26 名成年人(10 名女性,16 名男性),他们在 2019 年被风湿病学家确诊为 axSpA。焦点小组持续约 2 小时,录音、转录,并进行双重编码。审查的代码与患者的诊断经验有关。
患者描述了令人沮丧且漫长的诊断过程。他们认识到 axSpA 诊断延迟的原因是多方面的(例如,没有明确的诊断测试、疾病特征、初级保健提供者对 axSpA 的认识不足、信任)。患者描述了医生如何最小化或忽视对症状的抱怨,或告诉他们他们的问题是心身疾病。患者认为医疗保健系统导致了诊断延迟(例如,临床就诊时间不足、难以获得风湿病专家、健康保险挑战)。减少诊断延迟的建议包括医生允许患者充分描述他们的疾病经历、倾听和信任患者、及早转介到风湿病科、提供 HLA-B27 基因检测、医生需要与患者合作。
患者希望有一种能够在 axSpA 病程早期进行的明确测试。在这种测试可用之前,患者希望临床医生倾听、信任并与他们合作,并将他们一直跟进直到诊断出疾病。教育初级保健临床医生关于 axSpA 的诊断指南和转诊可能会减少诊断延迟。